Board

BOARD

Jonathan Waldstreicher, Principal, Apple Tree Partners

Jonathan Waldstreicher, Principal, joined Apple Tree Partners in 2013 to invest in medical devices. After incubating an interventional pulmonary technology for two years, Jon founded Gala Therapeutics in Silicon Valley and assumed the CEO role to further its development.

Prior to joining ATP, Jon was a Director, Global Surgery R&D, at Johnson & Johnson where he initiated and led an investment strategy and R&D development program in a new growth platform technology area. He started at Johnson & Johnson as an Associate Director in the Corporate Office of Science & Technology where he executed numerous seed grants to startup companies and participated in technical diligence of venture capital investments. Before medical school, Jon worked in Equity Research at Bear Stearns.

Jon received a B.A. from Brandeis University in Economics and an M.D. and M.B.A. from Tufts University School of Medicine where he was awarded the Norman Stearns award for highest achievement and overall excellence within the dual degree program. Between his third and fourth year of medical school, Jon worked as a fellow at the Corporate Office of Science & Technology at J&J. He completed a General Surgery Internship at Tufts Medical Center in Boston.

David McIntyre, Partner, Apple Tree Partners

David has over 20 years of experience as a senior executive and corporate advisor with multinational and growth companies in a wide variety of industries, including medical devices. With professional qualifications in finance and law, David has held senior financial, legal and operational roles.

More recently, David was Executive Vice President, Chief Financial Officer of HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) from 2005 through 2011, and assumed the additional responsibilities of Chief Operating Officer during HeartWare’s global commercialization phase for the period from 2008 through 2011.

Prior to HeartWare, David practiced as a senior attorney in private practice specializing in corporate, mergers and acquisitions and equity capital markets with Baker & McKenzie and KPMG as well as holding various senior financial roles in multi-national companies including Coal & Allied Limited, a publicly traded subsidiary of the Rio Tinto Group of companies.

David holds a Bachelor of Economics (Accounting) from the University of Sydney (Australia), a Bachelor of Law from the University of Technology, Sydney (Australia) and a Masters of Business Administration (Fuqua Scholar) from Duke University. He is also a Certified Practicing Accountant (CPA) and is admitted as a Legal Practitioner of the Supreme Court of New South Wales (in Australia).

Amir has over 26 years of operating experience in the healthcare industry focused on developing and commercializing cardiovascular devices, dental products, hearing prosthetics, and genomic diagnostics & analytics. Amir was the inventor and founder of Sonitus Medical in 2006, a novel non-surgical hearing prosthetic designed for treatment of unilateral deafness, and Sonitus Technologies in 2010. Prior to Sonitus, Amir held a variety of executive positions at Align Technology, Embolic Protection, and EndoTex as well as engineering roles at Pfizer, Guidant, and Baxter-Edwards. Amir holds over 100 issued patents.

Amir received an MS in Engineering Management from the University of Southern California and a BS in Biomedical Engineering from the University of California, San Diego.